<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article article-type="brief-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Allergy</journal-id><journal-title-group>
<journal-title>Frontiers in Allergy</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Allergy</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2673-6101</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/falgy.2025.1729120</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Research Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Economics of compliance for mixing allergy immunotherapy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Trapanotto</surname><given-names>Katarina I.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/3249409/overview"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role></contrib>
<contrib contrib-type="author"><name><surname>Lee-Wong</surname><given-names>Mary F.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Promisloff</surname><given-names>Robert A.</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Szema</surname><given-names>Anthony M.</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1358018/overview" /><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Stony Brook University School of Nursing</institution>, <city>Stony Brook</city>, <state>NY</state>, <country country="us">United States</country></aff>
<aff id="aff2"><label>2</label><institution>Icahn School of Medicine at Mount Sinai</institution>, <city>New York</city>, <state>NY</state>, <country country="us">United States</country></aff>
<aff id="aff3"><label>3</label><institution>Maimonides Medical Center</institution>, <city>Brooklyn</city>, <state>NY</state>, <country country="us">United States</country></aff>
<aff id="aff4"><label>4</label><institution>Drexel University College of Medicine</institution>, <city>Philadelphia</city>, <state>PA</state>, <country country="us">United States</country></aff>
<aff id="aff5"><label>5</label><institution>Donald and Barbara Zucker School of Medicine at Hofstra/Northwell</institution>, <city>Hofstra</city>, <state>NY</state>, <country country="us">United States</country></aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Katarina I. Trapanotto <email xlink:href="mailto:ktrapanotto@gmail.com">ktrapanotto@gmail.com</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-01-13"><day>13</day><month>01</month><year>2026</year></pub-date>
<pub-date publication-format="electronic" date-type="collection"><year>2025</year></pub-date>
<volume>6</volume><elocation-id>1729120</elocation-id>
<history>
<date date-type="received"><day>20</day><month>10</month><year>2025</year></date>
<date date-type="rev-recd"><day>22</day><month>11</month><year>2025</year></date>
<date date-type="accepted"><day>02</day><month>12</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2026 Trapanotto, Lee-Wong, Promisloff and Szema.</copyright-statement>
<copyright-year>2026</copyright-year><copyright-holder>Trapanotto, Lee-Wong, Promisloff and Szema</copyright-holder><license><ali:license_ref start_date="2026-01-13">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license>
</permissions>
<abstract>
<p>United States Pharmacopeia (USP), a nonprofit organization that sets safety standards for food, medicine and supplements updated its Chapter 797 standards for the preparation of allergy immunotherapy vials in November 2023. These guidelines impacted facility and personnel qualifications, workflow, and laboratory documentation. We hypothesized adhering to regulations may be financially difficult for allergy practices. To comply, offices must either use mail order prescription facilities or allocate financial resources to purchase a Primary Engineering Control (PEC) Hood, a device used to protect against airborne contaminants, or build-out an Allergenic Extract Compounding Area (AECA), a room specialized for compounding allergens. We performed a comparative analysis to determine financial feasibility of these three scenarios with the support of a Public Service Enterprise Group (PSEG) grant. Of these three options prescription sets were most costly, followed by PEC Hood and AECA. For both PEC Hood and AECA, costs were recouped by the third week of operation. In conclusion, for long term operation, the AECA would be most feasible for small private practice outpatient clinics in regard to overall cost and estimated revenue.</p>
</abstract>
<kwd-group>
<kwd>Allergenic Extracts Compounding Area (AECA)</kwd>
<kwd>Primary Engineering Control (PEC) Hood</kwd>
<kwd>United States Pharmacopeia (USP)</kwd>
<kwd>chapter 797</kwd>
<kwd>allergenic extract</kwd>
<kwd>immunotherapy</kwd>
<kwd>economics</kwd>
<kwd>costs analysis</kwd>
</kwd-group><funding-group><award-group id="gs1"><funding-source id="sp1"><institution-wrap><institution>Public Service Enterprise Group Foundation</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/100029221</institution-id></institution-wrap></funding-source></award-group><funding-statement>The author(s) declared that financial support was received for this work and/or its publication. We performed a comparative analysis to determine financial feasibility of these three scenarios with the support of a Public Service Enterprise Group (PSEG) grant.</funding-statement></funding-group><counts>
<fig-count count="3"/>
<table-count count="2"/><equation-count count="0"/><ref-count count="8"/><page-count count="5"/><word-count count="2188"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Allergen Immunotherapy</meta-value></custom-meta></custom-meta-group>
</article-meta>
</front>
<body><sec id="s2" sec-type="intro"><title>Introduction</title>
<p>USP is an independent scientific nonprofit organization that addresses quality assurance, enhancing regulatory predictability and is involved with manufacturers&#x0027; medicine distribution (<xref ref-type="bibr" rid="B1">1</xref>). USP regulates dietary supplements, medications, and healthcare quality with routine updating.</p>
<p>Chapter 797 regulates the sterility of labeled compounded preparations since failure to adhere could induce harm or death (<xref ref-type="bibr" rid="B2">2</xref>). Compliance entails compounding in an AECA or inside a PEC. AECA regulations require a visible perimeter with sufficient lighting, temperature and humidity controls, no carpeting or dust collecting overhangs. All surfaces, fixtures, and shelving must be free of crevices and are mandated to be cleaned by 70&#x0025; sterile isopropyl alcohol. While compounding in the AECA room, only authorized personnel donning PPE (Protective Personal Equipment) can be present (<xref ref-type="bibr" rid="B3">3</xref>). ISO (International Organization of Standards) Class V PEC requires biannual certification and disinfection with 70&#x0025; sterile IPA. Both AECA and PEC must be located away from restrooms, warehouses, or food prep areas and cannot be adjacent to unsealed windows, doors that connect outdoors, nor near busy staff traffic. AECA and PEC must be at least one meter away from sinks.</p>
</sec>
<sec id="s3" sec-type="methods"><title>Methods</title>
<p>A comparative analysis was conducted to determine which option was most economically viable for an allergy practice: (1) ordering prescription allergen extract sets from vendors (2) installation of PEC, (3) construction of AECA. Prescribed allergen extracts costs from Stallergenes Greer&#x2122; were used for calculations. PEC estimate included fume hood and certification cost. AECA cost entails room conversion and materials.</p>
<p>Prescription allergen extract costs, derived from Stallergenes Greer&#x2122;, included a five-vial starter set containing 5&#x2005;mL vial of maintenance concentrate plus four-step down dilution vials plus shipping. New York state insurance reimbursement was included to calculate final net cost.</p>
<p>PEC cost included an 18-inch PEC Hood model from Sentry Air Systems plus certification and inspection quotes from Technical Safety Services Inc.</p>
<p>Materials for the AECA included, bacteriostatic curtains with track, class 100 pre-saturated wipes with sterile 70&#x0025; IPA (isopropyl alcohol), cleanroom bouffant, washable ceiling tiles, humidifier/dehumidifier, temperature and humidity monitor, industrial nitrile gloves, MERV-13 (Minimum Efficiency Reporting Value) HEPA (High-Efficiency Particulate Air) filter, standard shoe covers, surgical masks, isolation gowns, laminate countertops with storage, licensed contractor, Ultraviolet-C plug-in air sanitizer, pre-catalyzed waterborne epoxy paint, and sheet rock (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" position="float"><label>Table&#x00A0;1</label>
<caption><p>Materials and construction costs for AECA.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" colspan="3">AECA Materials and Construction Cost</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Bacteriostatic Curtains with Track</td>
<td valign="top" align="left">2 Sets</td>
<td valign="top" align="center">&#x0024;700.00</td>
</tr>
<tr>
<td valign="top" align="left">Class 100 Pre-Saturated Wipes Sterile 70&#x0025; IPA</td>
<td valign="top" align="left">24 Packs, 30 wipes per pack</td>
<td valign="top" align="center">&#x0024;192.00</td>
</tr>
<tr>
<td valign="top" align="left">Cleanroom Bouffant</td>
<td valign="top" align="left">5&#x2013;8 Cases, 1,000 per case</td>
<td valign="top" align="center">&#x0024;350.00</td>
</tr>
<tr>
<td valign="top" align="left">Gypsum Ceiling Tiles</td>
<td valign="top" align="left">3 Cases, 48 tiles</td>
<td valign="top" align="center">&#x0024;190.00</td>
</tr>
<tr>
<td valign="top" align="left">Humidifier/Dehumidifier</td>
<td valign="top" align="left">1 Unit</td>
<td valign="top" align="center">&#x0024;90.00</td>
</tr>
<tr>
<td valign="top" align="left">Humidity and Temperature Monitor</td>
<td valign="top" align="left">1 Unit</td>
<td valign="top" align="center">&#x0024;45.00</td>
</tr>
<tr>
<td valign="top" align="left">Industrial Nitrile Gloves</td>
<td valign="top" align="left">1 Case, 1,000 pairs</td>
<td valign="top" align="center">&#x0024;45.00</td>
</tr>
<tr>
<td valign="top" align="left">MERV-13 HEPA Filter</td>
<td valign="top" align="left">1 Unit</td>
<td valign="top" align="center">&#x0024;65.00</td>
</tr>
<tr>
<td valign="top" align="left">Sealed Alarm Window</td>
<td valign="top" align="left">Preexisting</td>
<td valign="top" align="center">&#x0024;0.00</td>
</tr>
<tr>
<td valign="top" align="left">Standard Shoe Covers</td>
<td valign="top" align="left">2 Cases, 300 per case</td>
<td valign="top" align="center">&#x0024;70.00</td>
</tr>
<tr>
<td valign="top" align="left">Surgical Masks</td>
<td valign="top" align="left">2 Boxes, 100 per box</td>
<td valign="top" align="center">&#x0024;40.00</td>
</tr>
<tr>
<td valign="top" align="left">Isolation Gowns</td>
<td valign="top" align="left">3&#x2013;4 Cases, 50 per case</td>
<td valign="top" align="center">&#x0024;265.00</td>
</tr>
<tr>
<td valign="top" align="left">Laminate Countertops with Storage</td>
<td valign="top" align="left">Quote per Contractor</td>
<td valign="top" align="center">&#x0024;10,000.00</td>
</tr>
<tr>
<td valign="top" align="left">Licensed Contractor</td>
<td valign="top" align="left">1</td>
<td valign="top" align="center">&#x0024;4,000.00</td>
</tr>
<tr>
<td valign="top" align="left">UV-C Plug-in air Sanitizer</td>
<td valign="top" align="left">I Unit</td>
<td valign="top" align="center">&#x0024;64.00</td>
</tr>
<tr>
<td valign="top" align="left">Pre-Catalyzed Waterborne Epoxy Paint</td>
<td valign="top" align="left">2 Gallons</td>
<td valign="top" align="center">&#x0024;103.00</td>
</tr>
<tr>
<td valign="top" align="left">Drywall</td>
<td valign="top" align="left">Quote per Contractor</td>
<td valign="top" align="center">&#x0024;2,500.00</td>
</tr>
<tr>
<td valign="top" align="left">Estimated Total Cost</td>
<td valign="top" align="left"/>
<td valign="top" align="center">&#x0024;18,719.00</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s4" sec-type="results"><title>Results</title>
<p>Of the three allergenic manufacturers in the United States, Stallergenes Greer&#x2122;, HollisterStier Allergy&#x2122;, and ALK Allergy&#x2122;, only Stallergenes Greer&#x2122; ships patient-prescription bottles to medical offices. A five-vial starter set consisting of one 5&#x2005;mL maintenance bottle plus respective dilutions will vary in cost depending on the number of antigens included eg: less than 6 antigens is priced at &#x0024;498.53, 7&#x2013;12 antigens &#x0024;565.43, and 13&#x2013;15 antigens &#x0024;660.15 (<xref ref-type="bibr" rid="B4">4</xref>). Pricings do not include shipping cost, which is an additional estimated &#x0024;80&#x2013;100 for priority overnight shipping (<xref ref-type="bibr" rid="B4">4</xref>). Total equates to &#x0024;598.53, plus shipping. Prices are effective until March 1st, 2025. New York median reimbursement rate for three allergens from two allergy practices is approximately &#x0024;300. Result is a net loss of &#x0024;298.53 for every three allergen sets (&#x0024;598.53&#x2013;&#x0024;300&#x003D;&#x0024;298.53), indicating that ordering prescription allergy sets is not economically feasible (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>).</p>
<fig id="F1" position="float"><label>Figure&#x00A0;1</label>
<caption><p>Graph comparing the long term compliance of AECA and PEC hood, demonstrating PEC hood exceeding AECA costs by year seven.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="falgy-06-1729120-g001.tif"><alt-text content-type="machine-generated">Line graph showing costs over time. The blue line represents the PEC Fume Hood, increasing steadily from below $5,000 to above $35,000 over fifteen years. The red line represents AECA, remaining constant at $20,000 throughout.</alt-text>
</graphic>
</fig>
<p>PEC incurred a total cost of &#x0024;4,376.00 (&#x0024;1,976.00, hood cost, &#x002B;&#x0024;2,400, annual certification cost). Compliance requires particle count, air flow visualization as well as both surface and airborne colony sampling biannually.</p>
<p>AECA&#x0027;s cost was approximately &#x0024;18,719.00. Costs did not include the allergen extracts, wages nor personnel training. AECA rooms need to maintain sterility, but no certification required.</p>
</sec>
<sec id="s5" sec-type="discussion"><title>Discussion</title>
<p>Long term financial feasibility needs to be cognizant of income vs. expenses to determine whether an allergy practice survives. Allergy offices treat a median of fifty immunotherapy patients a week (<xref ref-type="bibr" rid="B5">5</xref>). Registered nurses hourly wage of &#x0024;45.42 for a 30-h week is a total &#x0024;1,362.60 per week (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). Stallergenes Greer&#x2122; 5&#x2005;mL allergenic vial costs within a range of &#x0024;110&#x2013;&#x0024;340, yielding a cost of &#x0024;5,500&#x2013;&#x0024;17,000 for fifty patients, thus a 20-week net loss of &#x0024;32,740.</p>
<p>CPT (Current Procedural Terminology) codes used for allergy immunotherapy reimbursement include: 95,115-one-injection, 95,117-multiple-injections, 95,165-vial-preparation-non-venom-antigens, and 95,144-single-dose-vial-preparation (<xref ref-type="bibr" rid="B8">8</xref>). Reimbursement median data from a New York City Community Hospital for one visit was &#x0024;24.56 (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>). Self-pay patients spend a range of &#x0024;120&#x2013;&#x0024;200 per visit depending on the number of allergy shots. This cost covers the vial and the administration of the shot. In addition, the &#x0024;24.56 worth of billing will be reimbursed for every visit. For a 20-week period for fifty patients, using the lower end of the range of &#x0024;120 and reimbursement, the gross profit yields &#x0024;72,280. Using the initial cost and the gross profit, the total profit is &#x0024;39,540 (<xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>). Total profits do not account for other forms of procedures that incur revenue, and total costs do not account for cleaning materials, office space costs, electricity and office maintenance.</p>
<table-wrap id="T2" position="float"><label>Table&#x00A0;2</label>
<caption><p>Reimbursement rates for common CPT codes.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">CPT Code</th>
<th valign="top" align="center">Description</th>
<th valign="top" align="center">2023 RVU</th>
<th valign="top" align="center">2023 National Payment Amount</th>
<th valign="top" align="center">Percent Change 2023&#x2013;2024</th>
<th valign="top" align="center">2024 RVU</th>
<th valign="top" align="center">2024 National Payment Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">95115</td>
<td valign="top" align="left">Immunotherapy, one injection</td>
<td valign="top" align="center">0.3</td>
<td valign="top" align="center">&#x0024;10.17</td>
<td valign="top" align="center">&#x2212;0.15&#x0025;</td>
<td valign="top" align="center">0.31</td>
<td valign="top" align="center">&#x0024;10.15</td>
</tr>
<tr>
<td valign="top" align="left">95117</td>
<td valign="top" align="left">Immunotherapy, two or more injections</td>
<td valign="top" align="center">0.35</td>
<td valign="top" align="center">&#x0024;11.86</td>
<td valign="top" align="center">2.15.&#x0025;</td>
<td valign="top" align="center">0.37</td>
<td valign="top" align="center">&#x0024;12.12</td>
</tr>
<tr>
<td valign="top" align="left">95144</td>
<td valign="top" align="left">Antigen therapy services (single dose vial)</td>
<td valign="top" align="center">0.5</td>
<td valign="top" align="center">&#x0024;16.94</td>
<td valign="top" align="center">&#x2212;3.37&#x0025;</td>
<td valign="top" align="center">0.5</td>
<td valign="top" align="center">&#x0024;16.37</td>
</tr>
<tr>
<td valign="top" align="left">95165</td>
<td valign="top" align="left">Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy; single or multiple antigens</td>
<td valign="top" align="center">0.45</td>
<td valign="top" align="center">&#x0024;15.25</td>
<td valign="top" align="center">&#x2212;5.52&#x0025;</td>
<td valign="top" align="center">0.44</td>
<td valign="top" align="center">&#x0024;14.41</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TF1"><p>Data is sourced from CMS medicare reimbursement rates.</p></fn>
</table-wrap-foot>
</table-wrap>
<fig id="F2" position="float"><label>Figure&#x00A0;2</label>
<caption><p>Graph illustrating financial viability of immunotherapy services in outpatient allergy clinics, showcasing net profits over operational costs.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="falgy-06-1729120-g002.tif"><alt-text content-type="machine-generated">Line graph depicting operational cost and cumulative gross profit over 20 weeks. The red line represents operational cost, gradually increasing. The blue line represents cumulative gross profit, increasing at a steeper rate.</alt-text>
</graphic>
</fig>
<p>Mail-order prescriptions set incurred a net loss of &#x0024;200 per set. One-year PEC cost was &#x0024;4,376.00 vs. &#x0024;18,719.00 costs for AECA. Initially, PEC was less costly than AECA but, year seven, PEC cost exceeded AECA due to maintenance and certification expenses. AECA and PEC costs are recouped by immunotherapy profits (<xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref>). Continued AECA operation requires additional cleaning materials and PPE. Prices are subject to change.</p>
<fig id="F3" position="float"><label>Figure&#x00A0;3</label>
<caption><p>Demonstrates the cost for the PEC hood, AECA, and mail order sets, showing mail order sets the costliest.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="falgy-06-1729120-g003.tif"><alt-text content-type="machine-generated">Line graph comparing cumulative costs over eleven years for three categories: PEC Hood Cost, AECA Cost, and Mail Order Sets Cost. The PEC Hood Cost and AECA Cost remain relatively low and stable, whereas the Mail Order Sets Cost increases significantly, surpassing three hundred thousand dollars by year eleven.</alt-text>
</graphic>
</fig>
<p>After a 3-week period of operation, calculated revenue exceeded both AECA and PEC cost, thus recuperating initial investments (<xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>).</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability"><title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7" sec-type="author-contributions"><title>Author contributions</title>
<p>KT: Writing &#x2013; original draft. ML-W: Writing &#x2013; review &#x0026; editing. RP: Writing &#x2013; review &#x0026; editing. AS: Writing &#x2013; review &#x0026; editing.</p>
</sec>
<ack><title>Acknowledgments</title>
<p>Special thanks to Architect Consultant Ruchira Das Madan M.Arch from Dasarc, a healthcare architecture and design firm on Long Island.</p>
</ack>
<sec id="s9" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s11" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><mixed-citation publication-type="book"><collab>US Pharmacopeia (USP)</collab> (<year>2024</year>). <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.usp.org/">https://www.usp.org/</ext-link> <comment>(Accessed September 24, 2024)</comment>.</mixed-citation></ref>
<ref id="B2"><label>2.</label><mixed-citation publication-type="book"><collab>797 FAQs</collab>. <publisher-name>US Pharmacopeia (USP)</publisher-name> (<year>2023</year>). <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://go.usp.org/USP_GC_797_FAQs">https://go.usp.org/USP_GC_797_FAQs</ext-link> <comment>(Accessed September 24, 2024)</comment></mixed-citation></ref>
<ref id="B3"><label>3.</label><mixed-citation publication-type="book"><collab>American Academy of Allergy, Asthma &#x0026; Immunology</collab>. <source><italic>AECA or PEC hood&#x2014;which will you choose?</italic></source> (<year>2023</year>). <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://education.aaaai.org/sites/default/files/media/2023-11/AECA%20or%20PEC%20Hood%20-%20which%20will%20you%20choose.pdf">https://education.aaaai.org/sites/default/files/media/2023-11/AECA&#x0025;20or&#x0025;20PEC&#x0025;20Hood&#x0025;20-&#x0025;20which&#x0025;20will&#x0025;20you&#x0025;20choose.pdf</ext-link> <comment>(Accessed November 11, 2024)</comment>.</mixed-citation></ref>
<ref id="B4"><label>4.</label><mixed-citation publication-type="book"><collab>A Worldwide Allergy Company</collab>. <source><italic>A worldwide allergy company</italic></source>. <publisher-name>Stallergenes Greer</publisher-name> (<year>2024</year>). <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.stallergenesgreer.com/">https://www.stallergenesgreer.com/</ext-link> <comment>(Accessed August 31, 2024)</comment>.</mixed-citation></ref>
<ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bingemann</surname> <given-names>T</given-names></name> <name><surname>Sharma</surname> <given-names>H</given-names></name> <name><surname>Nanda</surname> <given-names>A</given-names></name> <name><surname>Kahn</surname> <given-names>D</given-names></name> <name><surname>Markovics</surname> <given-names>S</given-names></name> <name><surname>Sussman</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>AAAAI work group report: physician wellness in allergy and immunology</article-title>. <source>J Allergy Clin Immunol Pract</source>. (<year>2020</year>) <volume>8</volume>(<issue>4</issue>):<fpage>1224</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaip.2020.01.023</pub-id><pub-id pub-id-type="pmid">32067926</pub-id></mixed-citation></ref>
<ref id="B6"><label>6.</label><mixed-citation publication-type="book"><collab>U.S. Bureau of Labor Statistics</collab>. <source><italic>Registered nurses</italic></source>. (<year>2024</year>). <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.bls.gov/oes/current/oes291141.htm">https://www.bls.gov/oes/current/oes291141.htm</ext-link> <comment>(Accessed August 11, 2024)</comment>.</mixed-citation></ref>
<ref id="B7"><label>7.</label><mixed-citation publication-type="book"><collab>HealthCare.gov</collab>. <source><italic>Full-time employee (FTE)&#x2014;glossary</italic></source> (<year>2024</year>). <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.healthcare.gov/glossary/full-time-employee/">https://www.healthcare.gov/glossary/full-time-employee/</ext-link> <comment>(Accessed August 11, 2024)</comment>.</mixed-citation></ref>
<ref id="B8"><label>8.</label><mixed-citation publication-type="book"><collab>CMS.gov</collab>. <source><italic>Billing and coding: allergen immunotherapy</italic></source>. <publisher-name>Centers for Medicare &#x0026; Medicaid Services</publisher-name> (<year>2024</year>). <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=57678%26ver=9">https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid&#x003D;57678&#x0026;ver&#x003D;9</ext-link> <comment>(Accessed August 31, 2024)</comment>.</mixed-citation></ref></ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by"><p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2047013/overview">Igor Kaidashev</ext-link>, Poltava State Medical University, Ukraine</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by"><p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2067275/overview">Sergii Zaikov</ext-link>, Shupyk National Medical Academy of Postgraduate Education, Ukraine</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2077910/overview">Svitlana Zubchenko</ext-link>, Danylo Halytsky Lviv National Medical University, Ukraine</p></fn>
</fn-group>
<fn-group>
<fn fn-type="abbr" id="abbrev1"><p><bold>Abbreviations</bold> AECA, allergenic extracts compounding area; PEC, primary engineering control; USP, United States Pharmacopeia; ISO, International Organization of Standards; MERV, minimum efficiency reporting value; HEPA, high-efficiency particulate air; PSEG, public service enterprise group; CSP, compounded sterile preparations; PPE, personal protective equipment; IPA, isopropyl alcohol; UV-C, ultraviolet-C; FTE, full time employee; CPT, current procedural terminology.</p></fn>
</fn-group>
</back>
</article>